Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Tochigi Cancer Center · National Cancer Center Hospital East · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
229
total citations
- FWCI
- 68.54
- Percentile
- 100%
- References
- 24
Citations per year
Authors
58- KNKohei NakachiCorresponding
Tochigi Cancer Center, National Cancer Center Hospital East
- MIMasafumi Ikeda
National Cancer Center Hospital East
- MKMasaru Konishi
National Cancer Center Hospital East
- SNShogo Nomura
Japan Clinical Cancer Research Organization
- HKHiroshi Katayama
Japan Clinical Cancer Research Organization
Topics & keywords
Topics
Keywords
- Medicine
- Clinical endpoint
- Gallbladder cancer
- Internal medicine
- Gallbladder
- Clinical trial
- Surgery
- Adverse effect
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.